PharmaShots | Incisive News in 3 Shots

Subscribe Now

Autoimmune

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

August 27, 2021

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs

August 27, 2021

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

May 6, 2021

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

May 6, 2021

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

May 6, 2021

AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B

AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B

September 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us